Gail S. Kerr
MD, FRCP
clinicaltrials@awirgroup.org
gail.kerr@awirgroup.org
To adequately treat our patients we rely on published data from clinical trials. We make our decisions on how to evaluate, diagnose, and treat our patients based on this valuable data. Join in on the forefront of gathering this information.
RHEUMATOID ARTHRITIS: DISEASE BURDEN REGISTRY (RADB)
RHEUMATOID ARTHRITIS DISEASE BURDEN REGISTRY (RADB)
Prospective Clinical Registry: Assessment of the Comorbidities, Disease Activity and Disease Burden in the Routine Clinical Care of Patients with RA
Contact: Gail S. Kerr MD FRCPGOUT
Pegloticase Clinical Trial www.clinicaltrials.gov NCT 02598596
Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect (TRIPLE)
Contact: Maggie Pugh 404-892-7002RHEUMATOID ARTHRITIS (VECTRA DA)
VECTRA DA Clinical Trial www.clinicaltrials.gov NCT02832297
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
Contact: David Chernoff, MD 650-351-3056RHEUMATOID ARTHRITIS (TARGET)
Treatments Against RA and Effect on FDG-PET/CT (TARGET) www.clinicaltrials.gov NCT02374021
Treatments Against RA and Effect on FDG-PET/CT (TARGET)
Contact: Rachel Broderick 212-342-2713